biomedcentral.com/content
Bottom,Top,Right1
  • Welcome Isis Pharmaceuticals Inc.
  • Log on
  • biomed central
  • chemistry central
  • SpringerOpen
BioMed Central
Advanced search
  • Home
  • Journals
  • Articles
  • Gateways
  • About BioMed Central
  • My BioMed Central

Submit a manuscript Register Sign up for article alerts Contact us

Institution search

Search by institution name/city

Members

  • Australia (21)
  • Austria (6)
  • Belgium (3)
  • Brazil (4)
  • Burkina Faso (1)
  • Canada (25)
  • Central African Republic (1)
  • China (3)
  • Cyprus (3)
  • Czech Republic (1)
  • Denmark (2)
  • Ethiopia (1)
  • Finland (6)
  • France (7)
  • Germany (51)
  • Ghana (3)
  • Greece (1)
  • Hong Kong (2)
  • Hungary (1)
  • India (8)
  • Ireland (1)
  • Israel (1)
  • Italy (16)
  • Kenya (3)
  • Korea, South (2)
  • Lebanon (1)
  • Lithuania (2)
  • Luxembourg (1)
  • Madagascar (1)
  • Malaysia (4)
  • Mexico (1)
  • Morocco (2)
  • Netherlands (11)
  • New Zealand (1)
  • Nigeria (2)
  • Norway (4)
  • Poland (2)
  • Portugal (1)
  • Romania (1)
  • South Africa (6)
  • Spain (13)
  • Sri Lanka (2)
  • Sweden (9)
  • Switzerland (10)
  • Taiwan (3)
  • Tanzania (3)
  • Thailand (1)
  • Trinidad and Tobago (1)
  • Uganda (1)
  • United Kingdom (49)
  • United States of America (159)

Advertisement

Supporter Member - Isis Pharmaceuticals Inc.

Isis Pharmaceuticals is exploiting its expertise in RNA to discover and develop novel human therapeutic drugs for patients. The company is also developing a biosensor to identify infectious organisms.

http://www.isispharm.com


Research staff and students at Isis Pharmaceuticals Inc.:

Do you realize that you will get a 15% discount on the article-processing charges of all research articles accepted for publication in journals published by BioMed Central ? Read more information about publishing your articles with us.



Work published with BioMed Central, Chemistry Central and SpringerOpen by researchers at Isis Pharmaceuticals Inc.

  • Latest RSS
  • Most viewed
  • Trending articles

Page 1 of 1

 Display/download options Articles per page: 25 | 50 | 100

Display options
Download optionsHelp icon

1.

Research   Open Access

Targeting density-enhanced phosphatase-1 (DEP-1) with antisense oligonucleotides improves the metabolic phenotype in high-fat diet-fed mice

Janine Krüger, Manuela Trappiel, Markus Dagnell, Philipp Stawowy, Heike Meyborg, Christian Böhm, Sanjay Bhanot, Arne Östman, Ulrich Kintscher, Kai Kappert Cell Communication and Signaling 2013, 11:49 (26 July 2013)

Abstract | Full text | PDF | PubMed

2.

Research article   Open Access Highly Accessed

Regulation of inflammatory arthritis by the upstream kinase mitogen activated protein kinase kinase 7 in the c-Jun N-Terminal kinase pathway

Sang-il Lee, David L Boyle, Andres Berdeja, Gary S Firestein Arthritis Research & Therapy 2012, 14:R38 (21 February 2012)

Abstract | Full text | PDF | PubMed

3.

Original investigation   Open Access Highly Accessed

Glucagon-like peptide-1 and the exenatide analogue AC3174 improve cardiac function, cardiac remodeling, and survival in rats with chronic heart failure

Que Liu, Christen Anderson, Anatoly Broyde, Clara Polizzi, Rayne Fernandez, Alain Baron, David G Parkes Cardiovascular Diabetology 2010, 9:76 (16 November 2010)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

4.

Original investigation   Open Access Highly Accessed

The exenatide analogue AC3174 attenuates hypertension, insulin resistance, and renal dysfunction in Dahl salt-sensitive rats

Que Liu, Lisa Adams, Anatoly Broyde, Rayne Fernandez, Alain D Baron, David G Parkes Cardiovascular Diabetology 2010, 9:32 (3 August 2010)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

5.

Research   Open Access Highly Accessed

Polyfunctional CD4+ T cell responses to a set of pathogenic arenaviruses provide broad population coverage

Maya F Kotturi, Jason Botten, Matt Maybeno, John Sidney, Jean Glenn, Huynh-Hoa Bui, Carla Oseroff, Shane Crotty, Bjoern Peters, Howard Grey, Daniel M Altmann, Michael J Buchmeier, Alessandro Sette Immunome Research 2010, 6:4 (17 May 2010)

Abstract | Full text | PDF | PubMed

6.

Software   Open Access Highly Accessed

ElliPro: a new structure-based tool for the prediction of antibody epitopes

Julia Ponomarenko, Huynh-Hoa Bui, Wei Li, Nicholas Fusseder, Philip E Bourne, Alessandro Sette, Bjoern Peters BMC Bioinformatics 2008, 9:514 (2 December 2008)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central |  Editor’s summary

The ElliPro software predicts and visualizes B-cell epitopes by implementing Thorntons simple method that uses geometrical properties of protein structures, outperforming six other structure-based methods without needing any training.

7.

Research article   Open Access Highly Accessed

The Microbial Rosetta Stone Database: A compilation of global and emerging infectious microorganisms and bioterrorist threat agents

David J Ecker, Rangarajan Sampath, Paul Willett, Jacqueline R Wyatt, Vivek Samant, Christian Massire, Thomas A Hall, Kumar Hari, John A McNeil, Cornelia Büchen-Osmond, Bruce Budowle BMC Microbiology 2005, 5:19 (25 April 2005)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

8.

Research article   Open Access

Serine / threonine protein phosphatase 5 (PP5) participates in the regulation of glucocorticoid receptor nucleocytoplasmic shuttling

David A Dean, Gudrun Urban, Ileana V Aragon, Mark Swingle, Beth Miller, Sandro Rusconi, Manuel Bueno, Nicholas M Dean, Richard E Honkanen BMC Cell Biology 2001, 2:6 (17 May 2001)

Abstract | Full text | PDF | PubMed | Cited on BioMed Central

Page 1 of 1


  • Terms and Conditions
  • Cookies
  • Privacy statement
  • Press
  • Information for advertisers
  • Jobs at BMC
  • Support
  • Contact us

© 2013 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.